A. Marangoni

Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes

E. Manzato, G. Di Giovanni, S. Morgante, 2022, Cardiovascular Diabetology.

Clinical Impact of 5 Years of Liraglutide Treatment on Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus in a Real-Life Setting in Italy: An Observational Study

L. Zenari, A. Lapolla, S. Lombardi, 2018, Diabetes Therapy.

Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.

A. Gallo, F. Piarulli, A. Pianta, 2015, Clinical therapeutics.

What are the preferred strategies for control of glycaemic variability in patients with type 2 diabetes mellitus?

L. Zenari, A. Marangoni, 2013, Diabetes, obesity & metabolism.

Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care

A. Filippi, A. Iovino, G. Beccuti, 2023, Diabetes Therapy.